Angelman Syndrome Video Assessment (ASVA) Source Material Study
Launched by THE EMMES COMPANY, LLC · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Caregiver reports that the individual with AS has a laboratory-confirmed diagnosis of Angelman syndrome
- • Individual with AS is at least 1 year old
- • Caregiver is willing and able to provide informed consent for themselves and oversee study participation
- • Caregiver or legal guardian is willing to provide informed consent on behalf of the individual with AS
- • Caregiver is comfortable reading and speaking in English
- • Caregiver has access to a smartphone or tablet that is compatible with the study app OR caregiver has internet access and is willing to use a wi-fi only device to record and upload videos
- NT-Caregiver dyads will be eligible for inclusion if the:
- • Neurotypical individual is between 1 and 8 years of age
- • Caregiver is willing and able to provide informed consent and oversee study participation and NT individual is willing and able to provide assent, as applicable
- • Caregiver is comfortable reading and speaking in English
- • Caregiver has access to a smartphone or tablet that is compatible with the study app OR caregiver has internet access and is willing to use a wi-fi only device to record and upload videos Participant-Caregiver dyads will be excluded from the study only if they do not meet the inclusion criteria above.
Trial Officials
Mindy Leffler
Principal Investigator
Casimir
About The Emmes Company, Llc
The Emmes Company, LLC is a global clinical research organization dedicated to advancing healthcare through innovative study design and robust data management. With expertise spanning various therapeutic areas, Emmes collaborates with biopharmaceutical companies, government agencies, and non-profit organizations to deliver comprehensive solutions that enhance clinical trial efficiency and regulatory compliance. Committed to scientific integrity and patient-centric approaches, Emmes leverages cutting-edge technology and a team of experienced professionals to drive meaningful results in the pursuit of better health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kingston, Massachusetts, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials